Elevance (ELV) PT Raised to $450 at Cantor Fitzgerald: Medicaid Cost Deterioration Unlikely
Tweet Send to a Friend
Cantor Fitzgerald analyst Sarah James raised the price target on Elevance (NYSE: ELV) to $450.00 (from $400.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
